--New Service Helps Customers to Treat More Patients Without Added Fixed Costs SUNNYVALE, Calif., Feb 20, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 10 percent of its U.S.
Study Abstract Recognized as Best Clinical Abstract at 2022 Radiosurgical Society Meeting SUNNYVALE, Calif. , March 31, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that long-term follow-up data from a study of men and women with trigeminal neuralgia (TN) showed 72
First Study to Evaluate the Use of Stereotactic Body Radiation Therapy in Low-Risk Prostate Cancer 10 Years Post Treatment SUNNYVALE, Calif. , Sept. 26, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective study of 230 men with low-risk prostate
Independent Data Confirms CyberKnife System is Only Radiosurgery Solution in Widespread Use for Extracranial Radiosurgery SUNNYVALE, Calif., June 20 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the latest utilization
25,000 Patients Treated with CyberKnife Radiosurgery During the Past Year Alone SUNNYVALE, Calif., Oct 06, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the
--Centennial Medical Center Brings Benefits of Whole Body Radiosurgery to Nashvilleto SUNNYVALE, Calif., June 24, 2009 /PRNewswire-FirstCall via COMTEX/ -- Centennial Medical Center Brings Benefits of Whole Body Radiosurgery to Nashville Accuray Incorporated (Nasdaq: ARAY), a global leader in the
SUNNYVALE, Calif., Sept. 23, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced details of the 2011 International Conference on TomoTherapy (ICT) , which took place September 16-17, 2011 hosted by the University of
This Recognition of Clinical Benefits Across Europe is Supported by Five-Year Outcomes for Low-Risk Prostate Cancer Patients Treated in Five Sessions SUNNYVALE, Calif., May 11, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery,
Presentations Highlight the Unmatched Clinical Excellence and Broad Range of Applications for the CyberKnife® and TomoTherapy® Systems SUNNYVALE, Calif. , Nov. 8, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that studies
SUNNYVALE, Calif. , Nov. 4, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the International Chamber of Commerce International Court of Arbitration (ICC) issued an interim award in an arbitration filed by Cowealth Medical Holding Co., Ltd.
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
